Authors
Latest:
Maximum (Un)Fair PriceHow pharmacies will pay for the Medicare Drug Price Negotiation Program
Latest:
A Review of FDA-Approved Medications for Chronic Weight ManagementFive medications are currently approved by the FDA for chronic weight management.
Latest:
Scripted for Her: Postpartum Care and Mental HealthIn this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, speaks with Lindsey Ferraro, PharmD, associate professor of pharmacy practice at Ohio Northern University.
Latest:
The Ever-Expanding Role of Consultant Pharmacists in Long-term CareClinical consultant pharmacists offer an individualized approach to the needs of long-term care facilities.
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Coming out of COVID: 5 Objectives for Boosting Rx Business and Cash Clinical ServicesOllin Sykes, CPA, CITP, and Scotty Sykes, CPA, CFP, discuss the business landscape after COVID within pharmacies and 5 objectives for focusing on growth again.
Latest:
Optimizing Multidisciplinary CarePanelists discuss how pharmacists can optimize multidisciplinary care for hypercortisolism by leveraging their training in chronic disease management and collaborative practice agreements to flag patients with persistent uncontrolled diabetes for screening, coordinate the diagnostic process and referrals to endocrinologists, and manage diabetes and hypertension while incorporating diabetes technology into treatment plans, and potentially oversee the use of newly approved medications like mifepristone for hypercortisolism treatment with appropriate monitoring for adverse effects like hypokalemia, while also exploring innovative solutions such as virtual care consultations, artificial intelligence–assisted imaging interpretation, and deprescribing of diabetes and blood pressure medications when hypercortisolism treatment successfully reduces cortisol levels.
Latest:
Practice Update: Treating Patients Hospitalized With COVID-19Several institutions have published guidance on how to treat patients hospitalized with COVID-19.
Latest:
Review of FDA Approvals for Pediatric Obesity ManagementGLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Latest:
Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.
Latest:
Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy SettingPharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations.
Latest:
Detecting Crossover Symptoms of COVID-19, InfluenzaAs respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.
Latest:
The Health Care Professional’s Role in Creating Equitable Patient OutcomesAn essay by Lord Simon Woolley that was published in BMJ calls on the medical community to speak up on how failed drug laws disproportionately harm black communities.
Latest:
Current and Future Treatments for Hidradenitis SuppurativaHidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.
Latest:
Pilot Program From Custom Health, L.A. Care, Tackles Medication AdherenceCustom is one of the growing number of companies focusing on adherence. It changed its name from Pack4U last year.
Latest:
Using Data to Put a Stop to Your Pharmacy's Profit LeakageTechnology will help you identify potential reimbursement problems before they trigger reduced payments or claims audits.
Latest:
Q&A: Pharmacy Teams Leverage Technology and Collaboration to Optimize Inventory | McKesson ideaShareThomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.
Latest:
FDA Accepts GSK's BLA for 5-in-1 Meningococcal VaccineThe company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Latest:
Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget CutsWith the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.
Latest:
Chewable Tablet Receives FDA Approval for Internal and External Parasites in DogsAfoxolaner, moxidectin, and pyrantel chewable tablets protect dogs from fleas, ticks, heartworm disease, roundworms, and hookworms.
Latest:
A Partnership to Optimize Medication Use and Patient OutcomesInitiative promotes adoption of value-based care models in community pharmacy settings.
Latest:
Sustaining Positivity Among Students, Professionals Critical for Pharmacy’s FutureA conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.
Latest:
COVID-19 Vaccines: A Focus on SafetyEase patients’ concerns by being well versed in the safety profiles of each vaccine.
Latest:
Healthy Margins: How Independent Pharmacies Can Strengthen Their Bottom LineIndependent pharmacists must not only prioritize patient care, but also financial stewardship, to maintain a confident business outlook amid industry headwinds.
Latest:
FDA Sets Review Date for Chronic Lung Disease Therapy BrensocatibFirst-in-class brensocatib has the potential to be the first approved treatment for bronchiectasis.
Latest:
Q&A: Pharmacists Can Help Raise Awareness About CGMsHeather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.
Latest:
The Ongoing Challenges Causing Need for Reform in Retail PharmacyAs state-level PBM reform heats up amid dire situations for many retail pharmacies, Walgreens Chief Pharmacy Officer Rick Gates joins Drug Topics to discuss ongoing industry challenges.
Latest:
Guselkumab Phase 3 Data Show Sustained Skin Clearance After 5 YearsTremfya phase 3 data shows skin clearance rates were maintained at 5 years with 55.5% of patients achieving an IGA score of 0% and 53% achieving PASI 100 response in VOYAGE 2 trial.
